Introduction:Basic information about CAS 406205-74-1|Bay 59-3074, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Bay 59-3074 |
|---|
| CAS Number | 406205-74-1 | Molecular Weight | 453.35600 |
|---|
| Density | 1.496g/cm3 | Boiling Point | 490.569ºC at 760 mmHg |
|---|
| Molecular Formula | C18H13F6NO4S | Melting Point | / |
|---|
| MSDS | / | Flash Point | 250.488ºC |
|---|
Names
| Name | [3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl] 4,4,4-trifluorobutane-1-sulfonate |
|---|
| Synonym | More Synonyms |
|---|
Bay 59-3074 BiologicalActivity
| Description | Bay 59-3074 is a novel, selective CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors respectively . Orally active CB1 agonist in vivo. target: CB1/CB2 receptor partial agonist.Ki: 48.3 and 45.5 nM (CB1 and CB2 receptors)In vitro: analgesic, antihyperalgesic, and antiallodynic properties in rat models of acute and chronic pain. The reference concentration is 10 μM. [1]In vivo: administration of BAY 59-3074 (ED50 value: 0.41 mg/kg).Orally active CB1 agonist in vivo. [2] BAY 59-3074 (0.3-3 mg/kg, p.o.) induce antihyperalgesic and antiallodynic effects against thermal or mechanical stimuli in rat models of chronic neuropathic. Antiallodynic efficacy of BAY 59-3074 (1 mg/kg, p.o.) in the spared nerve injury model was maintained after 2 weeks of daily administration. However, tolerance developed rapidly (within 5 days) for cannabinoid-related side effect. [1] BAY 59-3074 have analgesic, antihyperalgesic, and antiallodynic properties in rat models of acute and chronic pain.[1] |
|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>Cannabinoid ReceptorResearch Areas >>Cancer |
|---|
| References | [1]. De Vry J et al. 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novelcannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects. J Pharmacol Exp Ther. 2004 Aug;310(2):620-32 [2]. De Vry J et al. Discriminative stimulus effects of the structurally novel cannabinoid CB1/CB2 receptor partial agonist BAY 59-3074 in the rat. Eur J Pharmacol. 2004 Nov 28;505(1-3):127-33. |
|---|
Chemical & Physical Properties
| Density | 1.496g/cm3 |
|---|
| Boiling Point | 490.569ºC at 760 mmHg |
|---|
| Molecular Formula | C18H13F6NO4S |
|---|
| Molecular Weight | 453.35600 |
|---|
| Flash Point | 250.488ºC |
|---|
| Exact Mass | 453.04700 |
|---|
| PSA | 84.77000 |
|---|
| LogP | 6.50128 |
|---|
| Index of Refraction | 1.521 |
|---|
| InChIKey | LWUSZIVDPJPVBW-UHFFFAOYSA-N |
|---|
| SMILES | N#Cc1c(Oc2cccc(OS(=O)(=O)CCCC(F)(F)F)c2)cccc1C(F)(F)F |
|---|
| Storage condition | 2-8℃ |
|---|
Synonyms
| bay 59-3074 |
| hms3269k19 |
| unii-5fo5z101gu |